- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
India Glycols received stock exchange approvals ('No Objection' from NSE, 'No Adverse Observations' from BSE) for its demerger into Ennature Biopharma and IGL Spirits. The company will now seek NCLT approval, moving closer to completing the corporate restructuring.